Diversify Advisory Services’s Definium Therapeutics DFTX Stock Holding History

Diversify Advisory Services’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Buy	+10,025	New	+$248K	0.01%	917

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Diversify Advisory Services's DFTX Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 10,025 shares worth $428K. The stake represents 0.01% of the portfolio and ranks #917 among its holdings.

361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Diversify Advisory Services held 10,025 shares of Definium Therapeutics worth $428K as of Q2 2026.
Definium Therapeutics was a new Diversify Advisory Services position in Q2 2026.
Definium Therapeutics made up 0.01% of Diversify Advisory Services's portfolio in Q2 2026, its #917 holding.
361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.